Protek PAO operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Protek PAO with three other
pharmaceutical manufacturers in Europe:
Stada Arzneimittel AG
sales of 2.12 billion Euro [US$2.24 billion]
of which 58%
(3.88 billion Euro [US$4.10 billion]
of which 100%
was Biopharmacy), and
Lonza Group AG
based in Switzerland
(3.80 billion Swiss Francs [US$3.75 billion]
of which 57%
was Specialty Ingredients).
During the year ended December of 2015, sales at
Protek PAO were 195.31 billion Russian Rubles (US$3.27 billion).
increase of 24.4%
versus 2014, when the company's sales were 156.95 billion Russian Rubles.
This was the fifth consecutive year of sales increases at Protek PAO
(and since 2010, sales have increased a total of 96%).
Sales of Distribution saw an increase
24.7% in 2015, from
127.46 billion Russian Rubles to 158.94 billion Russian Rubles.